Bacterial and fungal cellular targets

Bacterial and fungal cellular targets represent a broad category of molecular structures and biochemical pathways essential for the survival and replication of pathogenic microorganisms (NIH, 2023). These targets are the primary focus of antimicrobial drug development and include cell wall components, protein synthesis machinery, and nucleic acid replication enzymes (StatPearls, 2024). In bacteria, key targets include penicillin-binding proteins (PBPs) and the 30S and 50S ribosomal subunits, while fungal targets often involve ergosterol synthesis or beta-glucan assembly (PubMed, 2022). Drugs such as beta-lactams, macrolides, and azoles interact with these specific sites to disrupt vital processes, resulting in either the death of the pathogen or the inhibition of its growth (Nature Reviews Microbiology, 2021). Because this term encompasses a vast array of distinct proteins and structures across different biological kingdoms, it is classified as a general grouping rather than a single, specific therapeutic target (CDC, 2023).

Other names

Antimicrobial targetsMicrobial targetsPathogen cellular targetsAntibiotic and antifungal targets

Antimicrobial agents targeting these sites function through several distinct mechanisms: inhibition of cell wall biosynthesis, disruption of cell membrane integrity, inhibition of protein synthesis by targeting ribosomal subunits, and interference with nucleic acid synthesis or function (StatPearls, 2024).